Matrix proteoglycans and remodelling of insterstitial lung tissue in lymphangioleiomyomatosis

Journal of Pathology

Volumn 203, Issue 2, 2004, Pages 653-660

  Merrilees, Mervyn J ^a   Hankin, Elyshia J ^a   Black, Judith L ^b   Beaumont, Brent ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b University of Sydney   (Australia)

Author keywords

Elastin; Interstitial tissue; Lymphagioleiomyomatosis; Proteoglycans; Versican

Indexed keywords

ACTIN; BIGLYCAN; BINDING PROTEIN; CELL PROTEIN; COLLAGEN; DECORIN; ELASTIN; MATRIX PROTEIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEOGLYCAN; TUBERIN; VERSICAN;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; ELASTIC FIBER; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS WALL; LUNG FIBROBLAST; LUNG PARENCHYMA; LUNG VOLUME; LYMPHANGIOLEIOMYOMATOSIS; MORPHOMETRICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TISSUE REPAIR;

ACTINS; COLLAGEN; ELASTIN; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; LUNG; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; MUSCLE, SMOOTH; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; PULMONARY ALVEOLI; RECEPTORS, CELL SURFACE; VERSICANS;

EID: 2642550680     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1577     Document Type: Article

References (23)

1. Sullivan EJ. Lymphangioleiomyomatosis: a review. Chest 1998; 114: 1689-1703.
2. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. PNAS 2000; 97: 6085-6090.
3. Wight T. Arterial wall. In Extracellular Matrix, Tissue Function, Comper WD (ed), vol 1. Harewood Academic Publishers: The Netherlands, 1996; 175-202.
4. Merrilees MJ. Beaumont B, Scott LJ. Comparison of deposits of versican, biglycan and decorin in saphenous vein and internal thoracic, radial and coronary arteries: correlation to patency. Coron Artery Dis 2001; 12: 7-16.
5. Evanko S, Angello J, Wight T. Formation of hyaluronan and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 1004-1013.
6. Hinek A, Mecham R, Keeley F, Rabinovitch M. Impaired elastin fibre assembly relation to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. J Clin Invest 1991; 88: 2083-2094.
7. Merrilees MJ, Lemire JM, Fischer JW, et al. Retrovirally mediated overexpression of versican V3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fibre formation in vitro and in neointima after vascular injury. Circ Res 2002; 90: 481-487.
8. Hinck A, Boyle J, Rabinovitch M. Vascular smooth muscle cell detachment from elastin and migration through elastic laminae is promoted by chondroitin sulfate-induced 'shedding' of the 67-kDa cell surface elastin binding protein. Exp Cell Res 1992; 203: 344-353.
9. Aherne W, Dunnill M. Point counting and the estimation of volume fraction. In Morphometry. Edward Arnold: London, 1982; 33.
10. Carrington CB, Cugell DW, Gaensler EA, et al. Lymphangioleiomyomatosis: physiologic-pathologic-radiologic correlations. Am Rev Respir Dis 1977; 116: 977-995.
11. Fukuda Y, Kawamoto M, Yamamoto A, Ishizaki M, Basset F, Masugi Y. Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangioleiomyomatosis. Hum Pathol 1990; 21: 1252-1261.
12. Hayashi T, Fleming MV, Stetler-Stevenson WG, et al. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol 1997; 28: 1071-1078.
13. Matsui K, Takeda Z, Yu Z, Travis D, Moss J, Ferrans VJ. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis. Arch Pathol Lab Med 2000; 124: 267-275.
14. Zhe X, Yang S, Jakkaraju S, Schuger L. Tissue inhibitor of metalloproteinase-3 downregulation in lymphangioleiomyomatosis: potential consequence of abnormal serum response factor expression. Am J Respir Cell Mol Biol 2003; 28: 504-511.
15. Sobonya RE, Quart SF, Fleishman JS. Pulmonary lymphangioleiomyomatosis: quantitative analysis of lesions producing airflow limitation. Hum Pathol 1985; 19: 1122-1128.
16. Kitaichi M, Nishimura K, Harumi I, Izumi T. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995; 151: 527-533.
17. Taveira-DaSilva AM, Hedin C, Stylianou MP, et al. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis. Am J Respir Crit Care Med 2001; 164: 1072-1076.
18. Peyrol S, Gindre D, Cordier JF, Loire R, Grimaud JA. Characterisation of the smooth muscle cell infiltrate and associated connective tissue matrix of lymphangioleiomyomatosis: immunohistochemical and ultrastructural study of two cases. J Pathol 1992; 168: 387-395.
19. Hinek A, Braun K, Liu K, Wang Y, Wight TN. Retrovirally mediated overexpression of versican V3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients. Am J Pathol 2003; 164: 133-141.
20. Wight T. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002; 14: 617-623.
21. Findlay GA, Hunter DS, Walker CL, Paulson KE, Fanburg BL. Regulation of PDGF production and ERK activation by estrogen is associated with TSC2 gene expression. Am J Physiol - Cell Physiol 2003; 282: C409-C418.
22. El-Hashemite N, Walker V, Zhang HB, Kwiatkowski DJ. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. Cancer Res 2003; 63: 5173-5177.
23. Inoue Y, King TE, Barker E, Daniloff E, Newman LS. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med 2002; 166: 765-773.